GLP-1 Receptor Agonists and Obesity-Related Cancer by Diabetes Severity

This cohort study examines the associations between glucagon-like peptide-1 receptor agonist (GLP-1 RA) initiation and obesity-related cancer incidence across active comparators and baseline type 2 diabetes severity.

Corresponding Author: Jesús Gibran Hernández-Pérez, PhD, MS, Peter O’Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 (JesusGibran.HernandezPerez@UTSouthwestern.edu).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.